We suggest the combination of high-dose glucocorticoids (or intravenous methylprednisolone) combined with intravenous immunoglobulin for new-onset sensory neuronopathy, followed by mycophenolate as maintenance therapy (Table 1)
Three things to remember: collagen peptides are the only option with robust human evidence, injectable peptides carry regulatory and safety considerations that oral collagen does not, and no peptide replaces proper medical evaluation for serious joint damage
Together, they create an environment optimized for both repair and enhancement
Several implications deserve attention
While generally safe, some side effects can include mild nausea, dizziness, or allergic reactions
We also offer in-office injections at our Nashville and Memphis locations for those who prefer professional administration